4.4 Article

Long non-coding RNA HOX transcript antisense RNA promotes expression of 14-3-3σ in non-small cell lung cancer

Journal

EXPERIMENTAL AND THERAPEUTIC MEDICINE
Volume 14, Issue 5, Pages 4503-4508

Publisher

SPANDIDOS PUBL LTD
DOI: 10.3892/etm.2017.5041

Keywords

long non-coding RNA; HOX transcript antisense RNA; 14-3-3 sigma; non-small cell lung cancer

Funding

  1. National Natural Science Foundation of China [81272584, 81602030]
  2. China Postdoctoral Science Foundation [2014RS4006]
  3. Hunan Province Natural Sciences Foundation of China [13JJ3039]

Ask authors/readers for more resources

Evidence suggests that both 14-3-3 sigma and long non-coding RNA HOX transcript antisense RNA (HOTAIR) are involved in the tumorigenesis and progression of lung cancer. In the present study, the potential association between 14-3-3 sigma and HOTAIR in non-small cell lung cancer (NSCLC) was investigated. In tissue samples collected from 54 patients with NSCLC, expression of HOTAIR and 14-3-3 sigma was analyzed by reverse transcription-quantitative polymerase chain reaction (RT-qPCR). After stable ectopic expression of HOTAIR and stable HOTAIR knockdown in PC9 cancer cells, the effect of HOTAIR on levels of mRNA and protein 14-3-3 sigma expression levels were detected using RT-qPCR and western blotting, respectively. Expression of HOTAIR and 14-3-3 sigma in NSCLC tissues was significantly higher than in adjacent non-cancerous lung tissue (P<0.05). Correlation analysis also identified a correlation between levels of HOTAIR and 14-3-3 sigma expression in NSCLC tissues (r=0.725, P=0.0005). In addition, overexpression and knockdown of HOTAIR in the human NSCLC cell line PC9 led to the upregulation and downregulation of 14-3-3 sigma, respectively, at both the mRNA and protein levels (all P<0.05). To the best of our knowledge, the present study provides the first in vivo and in vitro evidence to suggest that HOTAIR promotes the expression of 14-3-3 sigma in NSCLC. The potential association between HOTAIR and 14-3-3 sigma indicates that both biomolecules may be viable targets in anticancer therapy.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available